Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can ozonated oil soothe eczema in kids?

NCT ID NCT07744516

Disease control Sponsor: Laboratorios Ozoaqua Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial tests whether a topical ozonated vegetable oil can reduce the severity of mild-to-moderate atopic dermatitis (eczema) in children aged 1 month to 6 years. Over 14 days, researchers compare the oil against a placebo, measuring changes in a standard eczema severity score and quality of life. The goal is to see if this natural oil offers a safe and effective way to manage flare-ups in young patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a topical ozonated vegetable oil
What this could lead to
If effective, this could offer a natural, non-steroid option for managing eczema flare-ups in young children.
What could go wrong
The trial is small and short-term, so results may not apply broadly. The oil may not outperform the placebo, and skin irritation is possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Sep 2021

Finished

Apr 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

1 month to 6 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female patients aged between 1 month and 6 years. * Clinical diagnosis of atopic dermatitis. * Active mild or moderate flare. * Baseline SCORAD score between 20 and 50 points. * Availability of parents or legal guardians to administer the treatment and complete the follow-up period. * Written informed consent provided by the parents or legal guardians. Exclusion Criteria: * Severe atopic dermatitis. * Clinically relevant active skin infection. * Recent use of systemic immunosuppressive treatments. * Serious concomitant diseases. * Known hypersensitivity to any component of the formulation. * Clinical conditions that could interfere with the interpretation of the therapeutic response.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atopic dermatitis (AD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

atopic eczema Eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Atopic dermatitis (AD) Atopic dermatitis (eczema)

Contacts and locations

Locations

  • Alcantarilla-Sangonera Primary Care Centre

    Alcantarilla, Spain

  • Novelda Primary Care Centre

    Novelda, Spain

  • Torrevieja Hospital

    Torrevieja, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.